Upcoming Events
April 22-23
BioProcess International - Wien, Austria
Booth #2
May 13-16
Merck Technology Symposia - Long Branch, NJ
Booth #74
May 19-21
Biomarker World Congress - Philadelphia, PA
Booth # 41
June 1-5
American Society for Mass Spectrometry - Denver, CO
Booth #7
Podium Presentation
"Novel Global, Non-targeted Metabolomics Platform Utilizing UPLC and MS/MS Spectral Library Matching for Rapid Compound Identification"
by Annie Evans (Metabolon)
June 4
Past Events
April 12-16
AACR 2008 Annual Meeting - San Diego, CA
Booth #1749
Poster Presentation
Metabolomic profiling to identify biomarkers for hepatic radiation injury
by Rob Mohney (Metabolon)
April 15, 8:00 a.m. to 12:00 p.m.
Exhibit Hall B-F, Section 26, Board 12
April 5-9
Experimental Biology 2008 - San Diego, CA
Podium Presentation
"Identification of Non-Alcoholic Steatohepatitis (NASH) Using Plasma Metabolome in Humans"
by Satish Kalhan (Cleveland Clinic Foundation) and
Alvin Berger, MS, Ph.D.(Metabolon)
April 7, 8:00 to 10:00 a.m.
San Diego Convention Center, Room 25A
Poster Presentations
Metabolomics analysis of plasma from humans depleted of choline
by Wei Sha (UNC at Charlotte) and Alvin Berger, MS, Ph.D. (Metabolon)
April 6, 1:45 to 2:45 p.m.
Washington Convention Center, Program 688.8, Board C118
Identification of Non-Alcoholic Steatohepatitis (NASH) Using Plasma Metabolome in Humans
by Satish Kalha (Cleveland Clinic Foundation) and Alvin Berger, MS, Ph.D. (Metabolon)
April 8, 12:45 to 3:00 p.m.
San Diego Convention Center, Program 1162.5, Board E304
March 25-28
CHI Molecular Medicine Tri-Conference - San Francisco, CA
Booth #2
March 16-20
Society of Toxicology Annual Meeting - Seattle, WA
Exhibitor Booth #616
Poster Presentations
Effect of mainstream cigarette smoke gas/vapor phase and wet total particulate matter on the metabolic pathways of human lung epithelial cells: The metabolomic approach
by Suryanarayana Vulimiri (Lorillard)
March 18, 9:00 am to 12:30 pm
Poster 907, Board 543
Metabolomic Profiles of Liver and Plasma Following Whole-Liver Irradiation in Mice
by Rob Mohney (Metabolon)
March 19, 9:00 am to 12:30 pm
Poster 1600, Board 537
Metabolomic Analysis of Plasma and Urine in Rats Treated with Fenofibrate and Phenobarbital
by Mike Milburn (Metabolon) and Lining Guo (Metabolon)
March 19, 1:00 pm to 4:30 pm
Poster 1751, Board 225
January 7-9
CHI Peptalk Meeting - San Diego, CA
Booth #56
Podium Presentation
"Application of Metabolomics for Bioprocessing Optimization"
January 8, 12:30 p.m.
November 11 - 15
American Association of Pharmaceutical Scientists (AAPS) Annual Meeting - San Diego, CA
Exhibitor, Booth #3401
November 14
Dermal Clinical Evaluation Society Meeting - Fall Educational Seminar - Teaneck, NJ
Invited Speaker: Global Metabolomics Analysis in Drug Discovery and Development
Alvin Berger, Ph.D., Head of Biochemistry
November 5 - 6
Metabolome Symposium at the University of Tokyo - Tokyo, Japan
Invited Speaker: Mike Milburn, Ph.D., CSO
November 2 - 6
American Association of the Study of Liver Diseases Annual Meeting - Boston, MA
Metabolomics Workshop Co-chair
Alvin Berger, Ph.D., Head of Biochemistry
October 29 - 31
Cell and Tissue Bioprocessing - Austin, TX
Workshop, Wednesday, October 31, 9:30 - 10:00 am: Metabolomics for Bioprocessing Optimization
Chris Macri, Director, Business Development
October 22 - 26
AACR Molecular Targets and Cancer Therapeutics - San Francisco, CA
Exhibitor, Booth #318
Poster Presentation: GMX1777: a novel inhibitor of NAD+ biosynthesis via inhibition of nicotinamide phosphoribosyl transferase
Anne Roulston, Mark Watson, Cynthia Bernier, Helen Chan, Michel-Olivier Gratton, Anne Jang, Elizabeth Koch, Manon Lavoie, Denis Paquette, Matthew Mitchell*, Alvin Berger*, Laurent Belec, Xavier Billot, Gordon Shore, Pierre Beauparlant
Gemin X Biotechnologies Inc., 3576 Avenue du Parc, Suite 4310, Montréal, Québec, Canada H2X 2H7 *Metabolon, Inc. 800 Capitola Drive, Suite 1, Durham, NC 27713 USA
October 8 - 10
Genomes, Medicine, and the Environment 2007 - San Diego, CA
Invited Speaker: Global Metabolomics Analysis in Drug Discovery and Development
John Ryals, Ph.D., President and CEO
October 4 - 7
XVI International Symposium on Drugs Affecting Lipid Metabolism - New York, NY
Poster Presentation: A Comparative Metabolomic Analysis of PPARγ Activators for Evaluating Drug Efficacy and Safety
Alvin Berger, Ph.D., Head of Biochemistry
|
